Four major health issues today are blood sugar dysregulation, uncontrolled weight gain, dysregulation of dietary fats, and intestinal irritation. The first two have been addressed by the very popular pharmaceutical drug Ozempic. Unfortunately taking Ozempic has produced problematic side effects. For people looking for a natural alternative there is Akkermansia.

We all have bacteria in our intestines. Some good and some bad. Collectively, the bacteria inside of us is known as our “microbiome”. One of the beneficial bacteria in our microbiome is Akkermansia muciniphila.

Akkermansia is a beneficial gut bacterium that has been extensively studied for its potential positive effects on human health. Here are some key points about Akkermansia.

Akkermansia is a mucus digesting bacterium found in the human intestinal tract. It accounts for about 1-3% of the fecal bacteria found in healthy humans. It colonizes the gut during the first year of life and its prevalence can decrease with age or in disease states.

Akkermansia is associated with better metabolic and immune health. It will help strengthen gut integrity, modulate insulin resistance, and protect against metabolic inflammation. Akkermansia has been shown in studies to improve the health markers of obesity, glucose metabolism, and lipid metabolism.  

Akkermansia works by: digesting mucin in the gut, which may contribute to maintaining a healthy mucus layer; it produces beneficial compounds like short-chain fatty acids; and it balances the immune system and regulates inflammation.

Research on Akkermansia has shown a reduced abundance of this bacterium is associated with conditions like inflammatory bowel disease, obesity, and diabetes. And, that supplementation improved metabolic markers in overweight/obese humans in clinical trials. Animal studies show potential benefits for intestinal health, metabolism, and controlling gut and circulatory inflammation.

Akkermansia is a promising novel and low-risk treatment for blood sugar issues, weight gain, lipid (fat) metabolism imbalances, and intestinal irritation.